elranatamab   Click here for help

GtoPdb Ligand ID: 12889

Synonyms: elranatamab-bcmm | Elrexfio® | PF-06863135 | PF06863135
Approved drug Immunopharmacology Ligand
elranatamab is an approved drug (FDA & EMA (2023))
Compound class: Antibody
Comment: Elranatamab (PF-06863135) is a TNFRSF17(BCMA)/CD3e bispecific monoclonal antibody. It was designed to promote T cell-mediated anti-myeloma activity by simultaneously engaging these two protein targets on B and T cells [1,3].
Classification Click here for help
Compound class Antibody
Approved drug? Yes. FDA (2023)
International Nonproprietary Names Click here for help
INN number INN
11838 elranatamab
Synonyms Click here for help
elranatamab-bcmm | Elrexfio® | PF-06863135 | PF06863135
Database Links Click here for help
GtoPdb PubChem SID 485206010
Search PubMed clinical trials elranatamab
Search PubMed titles elranatamab
Search PubMed titles/abstracts elranatamab